Uscliner disclosed in an official announcement (in financial contexts, "announcement" is a more commonly used and precise term) that it has recently entered into a Strategic Cooperation Framework Agreement with Shenzhen Brain-Computer Starlink Technology Co., Ltd. (hereafter referred to as "Brain-Computer Starlink"). The two entities have forged a strategic partnership aimed at integrating brain-computer interface technology, clinical expertise, and market resources. Their joint efforts will focus on advancing the development of products currently under research, fostering market expansion and promotion, and elevating the diagnostic and treatment capabilities in areas such as central nervous system diseases. The agreement is set to remain in effect for a period of 5 years. It is not anticipated to exert a substantial influence on Uscliner's financial performance for the current fiscal year, with the impact on future performance contingent upon the progress of specific projects.